004 - Enabling Vaccine Manufacturing and Viral Vector Production using the iCELLis - a single-use, automated, and closed manufacturing platform

March 8, 2017

In this podcast, we were fortunate to have a group of experts for a panel discussion on vaccine manufacturing and viral vector production.

Interviewees:

  • Hanna P. Lesch, PhD, Research and Development Director at Finvector Vision Therapies
  • Jose Castillo, PhD, Co-Founder and CTO of Univercells
  • Mario Philips, Vice President and General Manager, Single-Use Technologies, Pall Life Sciences
  • Fabien Moncaubeig, Head of Cell Culture Technologies, Pall Life Sciences

Show Notes are available at: http://cellculturedish.com/2016/09/enabling-vaccine-manufacturing-and-viral-vector-production-using-the-icellis-a-single-use-automated-and-closed-manufacturing-platform

00:0000:00

Facebook Comments: